Gewinn- und Verlustrechnung von Amgen

zacks.com2026-08-21 10:51:07

Here's Why Amgen (AMGN) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

defenseworld.net2026-08-21 04:51:28

Bank of New York Mellon Corp Sells 97,857 Shares of Amgen Inc. $AMGN

Bank of New York Mellon Corp decreased its position in Amgen Inc. (NASDAQ: AMGN) by 2.6% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,695,586 shares of the medical research company's stock after selling 97,857 shares during the quarter. Bank of

fool.com2026-08-20 17:14:01

In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech?

VanEck's concentrated 25-stock biotech play offers higher volatility, while iShares' broader pharma exposure delivered a 1.4% dividend yield and lower drawdown risk.

zacks.com2026-08-20 11:11:07

Bet on These Biotech ETFs as Innovation Drives Market-Beating Growth

Biotech ETFs are riding a powerful rally fueled by innovation, obesity drugs and M&A, with three funds offering diversified exposure to growth.

defenseworld.net2026-08-20 04:43:26

Aegis Wealth Management LLC Invests $783,000 in Amgen Inc. $AMGN

Aegis Wealth Management LLC acquired a new stake in Amgen Inc. (NASDAQ: AMGN) in the undefined quarter, according to the company in its most recent filing with the SEC. The fund acquired 2,162 shares of the medical research company's stock, valued at approximately $783,000. Other institutional investors also recently modified their holdings of

defenseworld.net2026-08-20 03:37:01

Alpine Woods Capital Investors LLC Increases Stock Position in Amgen Inc. $AMGN

Alpine Woods Capital Investors LLC lifted its position in shares of Amgen Inc. (NASDAQ: AMGN) by 8.5% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 25,029 shares of the medical research company's stock after buying an additional 1,965 shares during the

247wallst.com2026-08-19 15:20:16

Which Drugmaker Stock Has Dominated in 2026: Merck, Pfizer, or Amgen?

Among U.S. large-cap drugmakers, one name has clearly outrun the pack in 2026 so far.

gurufocus.com2026-08-19 12:30:00

Amgen Stock Surges 3.5% as Healthcare Hits Record High

Amgen (AMGN), the biotech heavyweight behind Repatha, Enbrel and MariTide, surged roughly 3.5% to $440.08 Wednesday morning as healthcare stocks ripped to a rec

defenseworld.net2026-08-19 05:05:18

BlackRock Inc. Has $17.87 Billion Stock Holdings in Amgen Inc. $AMGN

BlackRock Inc. raised its position in Amgen Inc. (NASDAQ: AMGN) by 4.8% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 49,362,016 shares of the medical research company's stock after buying an additional 2,261,544 shares during the period. BlackRock Inc. owned about 9.15% of Amgen

defenseworld.net2026-08-18 04:39:51

Cane Capital Partners LLC Boosts Stake in Amgen Inc. $AMGN

Cane Capital Partners LLC raised its position in Amgen Inc. (NASDAQ: AMGN) by 73.2% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,259 shares of the medical research company's stock after purchasing an additional 1,377 shares during the quarter.

Erläuterung zur Gewinn- und Verlustrechnung

Erläuterung zur Ertragskraft

Gewinn- und Verlustrechnung von Amgen Inc.

Erläuterung zur Gewinn- und Verlustrechnung

Erläuterung zur Ertragskraft